
Über diesen Podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
396 Folgen · science
BioCentury This Week
Über diesen Podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Neue Folgen
- Ep. 385 - MFN deals, Lilly takeout, FDA pick Overton1. Sept. · 36 Min.
- Ep. 384 - Back to School Special: The global FIH trials race28. Aug. · 43 Min.
- Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick25. Aug. · 19 Min.
- Ep. 382 - Summer’s venture wave; drugging beta-catenin; Capricor & FDA18. Aug. · 25 Min.
- Ep. 381 - FIH urgency in the U.S. Plus: federated learning, biotech IPOs11. Aug. · 32 Min.
- Ep. 380 - AZ-BMS rumors, Replimune, psychedelics4. Aug. · 32 Min.
- Ep. 379 - Argenx M&A, AI giants and biopharma, catalyst scorecard28. Juli · 34 Min.
- Ep. 378 - U.K. cabinet shuffle, Taiwan biotech and Biogen data21. Juli · 42 Min.
- Ep. 377 - Trends in life sciences talent with CBRE's Ian Anderson15. Juli · 29 Min.
- Ep. 376 - M&A momentum: 3Q public markets preview14. Juli · 33 Min.